Cost-effectiveness of combining AI and cfDNA with LDCT for lung cancer screening in China: a modelling study
Background: Lung cancer remains one of the leading causes of cancer-related mortality in China, where early detection through screening is critical for improving survival rates. Low-dose computed tomography (LDCT) has proven effective for early lung cancer screening, but its high false-positive rate...
| Published in: | The Lancet Regional Health. Western Pacific |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666606524002876 |